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Introduction
Schwannomas are benign peripheral nerve tumors that can
be sporadic or familial in nature and typically associatedwith
neurofibromatosis type-2 (NF2).1 These tumors can affect
any point along the peripheral nerve, including the cranial
nerves, spinal roots, nerve plexi, and major peripheral
nerves. They can cause symptoms such as pain, weakness,
changes in sensation, and cranial nerve deficits, depending
on the nerve in question.
Certain syndromes such as NF2 are associated with an
increased frequency of schwannomas. For example, NF2 is
associated with bilateral vestibular schwannomas. Schwan-
nomatosis is another syndrome that appears to be a distinct
entity from NF2 in that patients may have multiple schwan-
nomas without any evidence of a vestibular nerve schwan-
noma or other findings associated with NF2.2–4 Prior reports
have demonstrated cases of schwannomatosis involving the
cranial nerves, spinal roots, major peripheral nerves, and
brachial or lumbar plexi.3,5However, as with neurofibromas,
cases of schwannomatosis involving the lower cranial nerves
(apart from the vestibulocochlear nerve) are rare.3,6–9 Here,
we report on a rare case of schwannomatosis involving the
left spinal accessory nerve and provide imaging findings and
a description of the surgical approach.
Case Report
History, Physical Examination, and Imaging Findings
This case is of a 55-year-old female who initially presented
with a palpable left neck mass. The mass had been noted by
the patient 8 years ago and had progressively grown in size. A
computed tomography (CT) of the neck was obtained, which
demonstrated a 3.5  2.3  4.6 cm lesion deep to the left
sternocleidomastoid (SCM) muscle in addition to a smaller
1  1  1.8 cm left posterior neck-enhancing mass. A fine
needle aspiration (FNA) had been performed 2 years prior at
an outside hospital with pathology indicating a low-grade
spindle cell proliferation. She was thus referred to our
institution for further evaluation. At the time of initial
presentation to our group, the patient had noted dysphagia,
left ear ache and tinnitus, and neck pain localized to the two
masses. A positron emission tomography (PET) CT was
performed, which demonstrated increased fluoro-2-deoxy-
D-glucose uptake in the high cervical mass and, to a
lesser degree, in the mass located within the posterior
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Abstract Schwannomatosis is a distinct syndrome characterized by multiple peripheral nerve
schwannomas that can be sporadic or familial in nature. Cases affecting the lower
cranial nerves are infrequent. Here, the authors present a rare case of schwannomatosis
affecting the left spinal accessory nerve. Upon genetic screening, an in-frame insertion
at codon p.R177 of the Sox 10 gene was observed. There were no identifiable
alterations in NF1, NF2, LZTR1, and SMARCB1. This case demonstrates a rare clinical
presentation of schwannomatosis in addition to a genetic aberration that has not been
previously reported in this disease context.
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triangle of the neck (►Fig. 1). The outside tissue blocks were
reviewed at our institution and felt to be consistent with a
peripheral nerve sheath tumor compatible with schwan-
noma from both lesions. Because of the patient’s ongoing
symptoms and because malignancy could not be completely
excluded based on the results of the prior FNA, the decision
was made to proceed with surgical excision of both lesions.
Prior to proceeding, a magnetic resonance neurogram was
obtained (►Fig. 2). Tractography demonstrated that the two
lesions appeared to originate from the spinal accessory nerve
and that apparent diffusion coefficient values were elevated
in both masses, supporting the diagnosis of a less aggressive
tumor (►Fig. 3).
Treatment Course
The patient was taken to the operating room for surgical
resection. The patient was positioned with her head turned
slightly to the right with the neck extended (►Fig. 4A). The
smaller lesion was approached first through the posterior
triangle of the neck. Stimulation mapping of the tumor was
conducted. The tumor was found to be located on the distal
spinal accessory (cranial nerve XI) nerve, with evidence of
trapezius activation with nerve stimulation (►Fig. 4B). After
identifying no overlying nerve fibers, the tumor was
removed en bloc. A separate incision was made in the upper
cervical region to approach the larger second mass located
lateral and deep to the SCM muscle, which was reflected
medially (►Fig. 4C). During dissection of the tumor away
from the nerve, motor evoked potentials (MEPs) to the
trapezius were lost. As the tumor was of significant size,
viewof the proximal aspect of the afferent nervewas initially
obstructed. Distally, the tumor was mapped, and the fascicle
of originwas identified, which appeared to activate the SCM.
After significant debulking of the mass, the proximal fascicle
of origin was identified but did not provide any muscle
activation after stimulation. The tumor was therefore
removed in its entirety. All parameters for brachial plexus
monitoring remained stable.
Pathological Findings and Clinical Outcome
Pathology for both lesions was consistent with schwannoma
without malignant features. Next-generation sequencing
analyzing the coding regions of 479 cancer genes as well
as select introns of 47 genes using the UCSF 500 Cancer Gene
Test revealed a small in-frame insertion at codon p.R177 of
the Sox 10 gene. There were no identifiable alterations in
NF1, NF2, LZTR1, SMARCB1, and TRAF7 genes. Despite the
change in MEPs, the patient was noted to be full strength in
all muscle groups in the left upper extremity including
shoulder shrug and head turning immediately
Fig. 1 (A–C) Positron emission tomography–computed tomography (PET CT) was performed, which demonstrated increased fluoro-2-deoxy-d-
glucose uptake in both masses (standardized uptake value of 7.3 for the larger mass and 2.7 for the smaller mass).
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postoperatively. At follow-up, her neck pain and prior dys-
phagia had improved significantly.
Discussion
Schwannomatosis is a syndrome characterized by multiple
peripheral nerve schwannomas usually without involve-
ment of the vestibular nerve and can be sporadic or familial
in nature. In a retrospective analysis of 87 patients with
schwannomatosis, 89% had peripheral tumors, 74% had
spinal tumors, and 9% had intracranial nonvestibular
tumors.9 The typical age of presentation is between 30 and
60 years, with pain being the most common presenting
symptom.9 Prevalence has been reported to be approxi-
mately 1 in 140,000 to 150,000,3,10 and life expectancy is
reported to be near-normal (76.9 years) and significantly
longer than for patients with NF2.3
Although there is phenotypic overlap with the other syn-
dromes under neurofibromatosis, such as NF2, schwannoma-
tosis is a distinct entity. Diagnostic criteria include at least two
nonintradermal anatomically distinct schwannomas (at least
onehistologicallyconfirmed)withno radiographicevidenceof
bilateral vestibular schwannomas on MRI and NF2 mutation
negative in a patient at least 30 years of age. Other criteria
include one biopsy-proven nondermal schwannoma or intra-
cranial meningioma plus a first-degree relative with schwan-
nomatosis. Although diagnostic criteria initially excluded
patientswith vestibular schwannomas, recent reports suggest
that schwannomatosis patients may still develop unilateral
vestibular schwannomas.11,12 Furthermore, intracranial
meningiomas or cutaneous neurofibromas do not exclude a
diagnosis of schwannomatosis, although other features of
other neurofibromatosis syndromes such as Lisch’s nodules
and café au lait macules are not present.
Fig. 2 Magnetic resonance imaging (MRI) neurogram demonstrated a larger 4.6  3.2  2.5 cm mass deep to the left sternocleidomastoid
muscle just below the angle of the mandible (A–C) and a bilobed 2.4  2.2  1.3 cm mass in the left posterior supraclavicular region (D–F).
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The most well-described genetic alteration is a mutation
in the SMARCB1 gene or LZTR1 gene on chromosome
22q11.2.13 In our case, these mutations were not present
and instead amutation in SOX10was observed.While SOX10
has been used previously as an identifying marker for
schwannomas, mutation of SOX10 as a contributor to the
pathogenesis of schwannomatosis, to our knowledge, has not
been previously reported.
Management of schwannomatosis patients represents
a therapeutic challenge. Typically, surgical intervention is
indicated for symptomatic lesions.5 We recommend the
use of intraoperative neuromonitoring for all cases with
the use of stimulation to help identify functional fascicles
that should be preserved. In this case, although injury was
sustained to the fibers of the spinal accessory nerve,
trapezius muscle innervation was maintained likely
because of the additional innervation of the trapezius
muscle by branches of the cervical plexus.14 Asympto-
matic tumors may be observed, but close imaging sur-
veillance is required. Further management considerations
include referral to a pain management specialist. In
the study by Merker et al, 68% of schwannomatosis
experienced chronic pain. Despite surgery and pain med-
ications, the majority did not become pain-free.9 Thus,
ongoing treatment under the care of a pain management
specialist is important from a quality-of-life standpoint.
Additionally, higher rates of depression and anxiety can
be seen in these patients, likely in the setting of chronic
pain, the source of which is often undiagnosed for
years. Active surveillance and treatment of mood disor-
ders is therefore another critical component of medical
care.9
Fig. 3 Further imaging characterization of lesions. (A) Diffusion tensor imaging with tractography demonstrated abnormal thickened nerve
fibers coursing through the two spinal accessory nerve tumors. (B) Axial diffusion weight imaging (left) and apparent diffusion coefficient (ADC)
images (right) of the lesions. ADC values were 1.3  106 and 1.8  106 mm2/second for the larger and smaller masses, respectively.
Fig. 4 Intraoperative findings. (A) Two separate incisions were required to remove both lesions. (B) The smaller bilobed lesion mass was
accessed through the posterior triangle of the neck and was located on the distal spinal accessory nerve. (C) The larger more proximal mass was
approached medial to the sternocleidomastoid muscle in the upper neck. Both masses underwent a gross total resection.
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Conclusion
Here, we report a rare case of schwannomatosis in addition
to a genetic aberration that has not been previously reported
in this disease context. Using intraoperative mapping and
microsurgical technique, safe resectionmay be attempted for
symptomatic lesions.
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